Managing particulates in cell therapy: Guidance for best practice

Area of Science:

• Cellular and Molecular Medicine
• Biotechnology
• Pharmaceutical Manufacturing

Background:

• Particulates can impact cell therapy product quality and patient safety.
• Manufacturing processes for cell therapies can inadvertently generate particulate matter.
• Standardized control strategies for particulates are needed across the industry.

Purpose of the Study:

• To provide comprehensive guidance on managing particulates in cell therapy manufacturing.
• To assist cell therapy sponsors and suppliers in identifying and controlling particulate sources.
• To offer recommendations for testing, monitoring, and controlling particulates throughout the manufacturing lifecycle.

Main Methods:

• Review of current industry practices and regulatory expectations.
• Identification of common particulate sources in cell therapy production.
• Development of a framework for particulate risk assessment and control.

Main Results:

• Established recommendations for characterizing particulate generation.
• Outlined strategies for effective particulate testing and monitoring.
• Provided methods for controlling particulates to ensure product quality.

Conclusions:

• Effective particulate control is crucial for the successful development and manufacturing of safe and effective cell therapies.
• Implementing the recommended strategies will enhance product consistency and patient safety.
• Industry-wide adoption of these guidelines will advance the field of cell therapy manufacturing.